LegoChem Biosciences Inc (141080) - Net Assets

Latest as of March 2026: ₩500.52 Billion KRW ≈ $339.20 Million USD

Based on the latest financial reports, LegoChem Biosciences Inc (141080) has net assets worth ₩500.52 Billion KRW (≈ $339.20 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₩652.93 Billion ≈ $442.48 Million USD) and total liabilities (₩152.41 Billion ≈ $103.29 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check LegoChem Biosciences Inc PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.

Key Net Assets Metrics

Metric	Value
Current Net Assets	₩500.52 Billion
% of Total Assets	76.66%
Annual Growth Rate	34.93%
5-Year Change	109.11%
10-Year Change	800.96%
Growth Volatility	99.21

LegoChem Biosciences Inc - Net Assets Trend (2014–2025)

This chart illustrates how LegoChem Biosciences Inc's net assets have evolved over time, based on quarterly financial data. For live market cap and overall valuation, see 141080 market cap overview.

Annual Net Assets for LegoChem Biosciences Inc (2014–2025)

The table below shows the annual net assets of LegoChem Biosciences Inc from 2014 to 2025. Also explore LegoChem Biosciences Inc equity growth rate to track the company's year-over-year net asset growth rate.

Year	Net Assets	Change
2025-12-31	₩541.12 Billion ≈ $366.71 Million	-12.16%
2024-12-31	₩616.00 Billion ≈ $417.45 Million	+315.59%
2023-12-31	₩148.22 Billion ≈ $100.45 Million	-32.50%
2022-12-31	₩219.60 Billion ≈ $148.82 Million	-15.14%
2021-12-31	₩258.77 Billion ≈ $175.37 Million	+130.79%
2020-12-31	₩112.13 Billion ≈ $75.99 Million	-1.43%
2019-12-31	₩113.75 Billion ≈ $77.09 Million	+11.89%
2018-12-31	₩101.66 Billion ≈ $68.90 Million	+110.89%
2017-12-31	₩48.21 Billion ≈ $32.67 Million	-19.74%
2016-12-31	₩60.06 Billion ≈ $40.70 Million	+39.10%
2015-12-31	₩43.18 Billion ≈ $29.26 Million	+115.42%
2014-12-31	₩20.04 Billion ≈ $13.58 Million	--

Equity Component Analysis

This analysis shows how different components contribute to LegoChem Biosciences Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have grown by 24023925800000.0% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2025)

Component	Amount	Percentage
Retained Earnings	₩211.81 Billion	41.73%
Other Components	₩295.81 Billion	58.27%
Total Equity	₩507.61 Billion	100.00%

LegoChem Biosciences Inc Competitors by Market Cap

The table below lists competitors of LegoChem Biosciences Inc ranked by their market capitalization.

Company	Market Cap
Polaris Bay Group Co Ltd SHG:600155	$1.98 Billion
Tung Ho Steel Enterprise Corp TW:2006	$1.98 Billion
AVI LTD (UNSP.ADR)/5 F:IZ60	$1.98 Billion
China Meheco Co Ltd SHG:600056	$1.98 Billion
Wasu Media Holding Co Ltd SHE:000156	$1.98 Billion
Pfizer Limited NSE:PFIZER	$1.98 Billion
Inno Laser Technology Co. Ltd. SHE:301021	$1.98 Billion
Anywhere Real Estate Inc NYSE:HOUS	$1.98 Billion

Equity Growth Attribution

This analysis shows how different factors contributed to changes in LegoChem Biosciences Inc's equity between the two most recent reporting periods.

Equity Growth Insights

From 2024 to 2025, total equity changed from 615,998,105,850 to 507,613,912,380, a change of -108,384,193,470 (-17.6%).
Net loss of 74,277,654,740 reduced equity.
Share repurchases of 6,996,191,000 reduced equity.
New share issuances of 7,238,893,000 increased equity.
Other factors decreased equity by 34,349,240,730.

Equity Change Factors (2024 to 2025)

Factor	Impact	Contribution
Net Income	₩-74.28 Billion	-14.63%
Share Repurchases	₩7.00 Billion	-1.38%
Share Issuances	₩7.24 Billion	+1.43%
Other Changes	₩-34.35 Billion	-6.77%
Total Change	₩-	-17.59%

Book Value vs Market Value Analysis

This analysis compares LegoChem Biosciences Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 5.75x
The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
The price-to-book ratio has decreased from 26.55x to 5.75x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2016-12-31	₩3020.78	₩80200.00	x
2017-12-31	₩2421.32	₩80200.00	x
2018-12-31	₩4800.09	₩80200.00	x
2019-12-31	₩5304.51	₩80200.00	x
2020-12-31	₩4734.30	₩80200.00	x
2021-12-31	₩10677.76	₩80200.00	x
2022-12-31	₩8610.70	₩80200.00	x
2023-12-31	₩5566.42	₩80200.00	x
2024-12-31	₩16978.06	₩80200.00	x
2025-12-31	₩13943.47	₩80200.00	x

Capital Efficiency Dashboard

This dashboard shows how efficiently LegoChem Biosciences Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): -14.63%
The company may be facing challenges in efficiently utilizing shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: -52.47%
• Asset Turnover: 0.20x
• Equity Multiplier: 1.38x
Recent ROE (-14.63%) is above the historical average (-18.84%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2014	-43.33%	-998.29%	0.03x	1.68x	₩-10.69 Billion
2015	-19.08%	-460.58%	0.03x	1.59x	₩-12.56 Billion
2016	-24.52%	-88.41%	0.19x	1.49x	₩-20.73 Billion
2017	-26.83%	-58.64%	0.27x	1.71x	₩-17.75 Billion
2018	-25.35%	-102.10%	0.21x	1.20x	₩-35.94 Billion
2019	11.94%	23.63%	0.41x	1.24x	₩2.21 Billion
2020	-6.23%	-14.14%	0.36x	1.21x	₩-18.20 Billion
2021	-9.04%	-72.74%	0.11x	1.13x	₩-49.27 Billion
2022	-20.53%	-134.96%	0.13x	1.15x	₩-67.05 Billion
2023	-49.73%	-215.85%	0.18x	1.28x	₩-88.53 Billion
2024	1.27%	6.20%	0.17x	1.20x	₩-53.80 Billion
2025	-14.63%	-52.47%	0.20x	1.38x	₩-125.04 Billion

Industry Comparison

This section compares LegoChem Biosciences Inc's net assets metrics with peer companies in the Biotechnology industry.

Industry Context

Industry: Biotechnology
Average net assets among peers: $357,982,769,079
Average return on equity (ROE) among peers: 0.67%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
LegoChem Biosciences Inc (141080)	₩500.52 Billion	-43.33%	0.30x	$1.98 Billion
ORIENTBIO Inc. (002630)	$67.35 Billion	-2.60%	1.21x	$149.07 Million
Green Cross (005250)	$1.51 Trillion	0.20%	0.84x	$289.90 Million
Green Cross Holdings Preference Shares (005257)	$1.76 Trillion	-3.94%	1.31x	$3.02 Million
Pharmicell (005690)	$63.87 Billion	14.80%	0.48x	$511.96 Million
GeneOne Life Science Inc (011000)	$33.79 Billion	0.00%	0.20x	$32.81 Million
HLB Co. Ltd (028300)	$21.19 Billion	0.00%	1.56x	$2.80 Billion
Mgenplus Co. Ltd. (032790)	$22.54 Billion	-9.92%	0.60x	$21.32 Million
Daesung Microbiological Labs. Co. Ltd (036480)	$37.35 Billion	-1.82%	0.72x	$15.73 Million
Seoulin Bioscience Co.Ltd (038070)	$41.57 Billion	10.01%	0.45x	$23.84 Million
Hyundai Bioscience Co. Ltd (048410)	$21.80 Billion	0.00%	0.41x	$446.67 Million

About LegoChem Biosciences Inc

KQ:141080 Korea Biotechnology

Market Cap

$1.98 Billion

₩2.92 Trillion KRW

Market Cap Rank

#6263 Global

#147 in Korea

Share Price

₩80200.00

Change (1 day)

-2.08%

52-Week Range

₩77900.00 - ₩213500.00

All Time High

₩213500.00